Chronic kidney disease (CKD) is a global public health problem that an estimated 843.6 million individuals are currently affected by various stages of the disease, whereas the prevalence of CKD is increasing, and Hong Kong is no exception1. Yet, the...
Early Blood Glucose Control as the Key to Preventing and Delaying Progression DM is the leading cause of CKD worldwide. The Hong Kong Central Renal Registry reported that diabetic nephropathy (DN) accounts for nearly 50% of patients who undergo dial...
Evaluating Clinical Data in Renal Impaired Subgroup Former meta-analysis demonstrated that the use of NOACs, i.e. rivaroxaban, edoxaban, dabigatran and apixaban, was associated with reduced risk of stroke and systemic embolism (SE) and reduced risk ...
Pathological Bases for Coexistence of CKD and AF Dr. Wang explained that CKD and AF may frequently co-exist in a patient. The 2 disorders share many common risk factors including hypertension, diabetes mellitus (DM), ischaemic heart disease, heart f...
On-treatment Case Patient 1 was a 45-year-old woman who had a strong family history of ADPKD. Her mother and affected maternal relatives started to receive dialysis in their fifties. Polycystic liver was also present. Over a year’s monitoring,...
